Comparison of two antilymphocyte globulins replacing cyclosporin A after first kidney allotransplantation and prolonged graft ischemia.
ATG/Fresenius (5 mg/kgBW) and ATGAM (Upjohn, 12.5 mg/ kgBW) replacing cyclosporin A were given during 7 d after transplantation to 20 patients in 1992 and 30 patients in 1993, respectively. Numbers of mismatches, combined kidney-pancreas transplantation and severe infections were not different for the two groups. However, prednisone pulse therapies and additional antilymphocyte globulin treatments were more frequent after ATGAM than after ATG induction (p < 0.01, chi 2-test).
Gantenbein
H
H
Department Internal Medicine, University Hospital Zürich, Switzerland.
Bachmann
P
P
Huynh
U
U
Steinhäuslin
F
F
Weinreich
T
T
Schlumpf
R
R
Largiadèr
F
F
Binswanger
U
U
D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use*; D006801:Humans; D007511:Ischemia / Q000150:complications*; D007668:Kidney / Q000098:blood supply*; D016030:Kidney Transplantation; D016035:Pancreas Transplantation; D011241:Prednisone / Q000008:administration & dosage; D012189:Retrospective Studies
D000961:Antilymphocyte Serum; D016572:Cyclosporine; D011241:Prednisone